CUE

Cue Biopharma Inc.

Price

$28.39

return (12m)

18.07%

p/e

-0.85

p/bv

60.21

DIVIDEND YIELD

0.00%

CUE price

Cue Biopharma

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CUE

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-2.24%

3 months

29.63%

1 year

18.07%

2 years

35.19%

5 years

-92.36%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals CUE

Valuation

P/E

-0.85

Sector -4.26

Industry -4.26

P/BV

60.21

Sector 2.11

Industry 2.11

P/Revenue (PSR)

3.69

Sector 2.08

Industry 2.08

EV/EBITDA

Sector -546.19

Industry -546.19

EV/EBIT

Sector -37.31

Industry -37.31

P/EBITDA

Sector -50.76

Industry -50.76

P/EBIT

Sector -39.62

Industry -39.62

P/Total Assets

4.53

Sector 1.25

Industry 1.25

P/Net Current Assets

-78.13

Sector -5.47

Industry -5.47

P/Working Capital

25.76

Sector -1.10

Industry -1.10

EPS

-27.35

Sector -1.94

Industry -1.94

BVPS

0.39

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

100.00%

Sector 38.90%

Industry 38.90%

EBITDA Margin

0.00%

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

0.00%

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

-100.00%

Sector -36.74%

Industry -36.74%

Net Profit Margins

-100.00%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.26

Sector 0.03

Industry 0.03

Profitability

ROE

-7,104.76%

Sector -61.50%

Industry -61.50%

ROA

-534.42%

Sector -63.85%

Industry -63.85%

ROIC

0.00%

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.25

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

0.00

Sector -0.60

Industry -0.60

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

0.08

Sector 0.43

Industry 0.43

Liabilities/Assets

0.92

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

20.31%

Sector -

Industry -

5Y Earnings CAGR

30.02%

Sector -

Industry -

Fundamentals CUE

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CUE Cue Biopharma Inc.	$28.39	14.62%	0.00%	-0.85	60.21	-7,104.76%	-100.00%
JNJ Johnson & Johnson	$266.50	55.29%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$27.87	21.03%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$256.91	27.42%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$45.62	-14.65%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$147.77	82.61%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$161.98	3.71%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.29	45.78%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$76.84	-49.43%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$792.43	37.47%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$432.42	55.55%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$105.00	43.48%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$897.16	31.93%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$542.40	39.41%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$235.19	59.60%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.29	3.26%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$217.24	59.31%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CUE Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Cue Biopharma

Cue Biopharma Inc.

Average Investor10 user rating

4.0 (1 people)

United States

12 years

Founded: 2014

2018

Time since IPO - 8 years

52

Employees

Cue Biopharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $139.08 million, with shareholders equity totaling $2.31 million.

The company employs approximately 52 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Cue Biopharma Inc. reported $37.66 million in revenue, generating net income of $-164.12 million.

Key financial metrics include a P/E ratio of -0.85, a price-to-book (P/B) ratio of 60.21, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CUE.

Market cap

$139.08 million

Net worth

$2.31 million

$2,310,000.00

Assets

$30.71 million

$30,710,000.00

Total Shares Outstanding

6.00 million

6,000,000

Average Daily Trading Volume

$165.31 Thousand

$165,308.82

Sector

Health Care

Industry

Biotechnology

CUE

CUE revenue and profits

Financial Results CUE

DRAG THE FRAME TO SEE MORE DATA

CUE cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$897.16 31,33% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$235.19 60,10% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$256.91 26,00% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$147.77 82,50% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$161.98 3,46% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$27.87 22,54% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$897.16 31,33% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$235.19 60,10% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$256.91 26,00% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$147.77 82,50% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$161.98 3,46% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$27.87 22,54% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Cue Biopharma (CUE) today?

A cotação de Cue Biopharma (CUE) hoje está em US$ 28.39, com uma variação de 18.07% em relação ao último ano. A cotação de Cue Biopharma (CUE) iniciou o ano negociando na casa dos US$ 0.31 e hoje está em US$ 28.39. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Cue Biopharma (CUE) e dados de ações do Ibovespa e mercados internacionais.

Quando Cue Biopharma (CUE) paga dividendos?

Cue Biopharma (CUE) não distribuiu dividendos no último ano.

Is Cue Biopharma (CUE) a good investment?

Atualmente, Cue Biopharma (CUE) está cotada a US$ 28.39, com um P/L de -0.85, representando um desvio de -4,585% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 18.07 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 18.07%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Cue Biopharma (CUE) stock?

Investir em ações de Cue Biopharma (CUE) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Cue Biopharma (CUE) yield today?

A rentabilidade de Cue Biopharma (CUE) foi de -2.24% no último mês, 18.07% no último ano e -92.36% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Cue Biopharma (CUE) hoje, o investimento total seria de US$ 2,839.00, com base na cotação atual de US$ 28.39.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 3,352.01
Em 5 anos: US$ 216.90
Em 10 anos: US$ 2,839.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

CUE

Cue Biopharma Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment CUE

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING CUE WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Cue Biopharma

Cue Biopharma Inc.

United States

12 years

2018

52

PROFIT X PRICE CUE

Financial Results CUE

CUE cash flow

Asset, Revenue and Profit Growth - CUE

CUE balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions